课题基金 / 基金详情

Adjusting our regulatory framework to fit the COVID world

Adjusting our regulatory framework to fit the COVID world
调整我们的监管框架以适应新冠疫情世界
批准号:
10024786
负责人:
金额:
$6.32万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们的目标是使心血管手术更加高效和安全。该项目开发了PreSize平台,这是一种新颖的临床决策支持解决方案,可帮助临床医生计划和排练血管内支架放置。使用尖端的计算模型,我们充分利用可用的患者扫描和支架设备力学来准确预测每个患者血管配置内设备的行为。这使临床医生能够优化设备选择,减少并发症的数量和医院和社会支架手术的相关成本。我们是一家新成立的公司,专门为医院提供这项技术。我们目前正在运行IUK生物医学催化剂引物(BMC-P)项目,该项目由英国皇家工程院孵化。我们之前的项目成果获得了许多奖项,包括2017年健康企业东部(HEE) NHS创新奖。我们被《连线》杂志评为“2018年最佳医疗保健初创企业”,并在著名的“2017年Medilink英国医疗保健商业奖”中获得全国冠军。我们被选为数字健康伦敦加速器(DHLA)计划的一部分,之前是飞利浦医疗保健加速器在全球范围内选择的6家初创企业之一,并在福布斯的两篇文章中被评为“努力改变世界的创始人”和“值得密切关注的英国新初创企业之一”,WIRED的两篇文章:“这些是你需要了解的医疗保健初创企业”和“从人工智能医生到3D x射线,医疗保健的未来已经到来”,并被《泰晤士报》、《金融时报》等媒体报道。我们的目标是将Oxford Heartbeat发展成为临床决策支持工具的领先提供商,以改善医疗保健并定义未来的医学。
英文摘要
Our goal is to make cardiovascular surgeries more efficient and safe. This project develops the PreSize platform, a novel clinical decision-support solution that helps clinicians plan and rehearse stent placements inside blood vessels. Using cutting- edge computational modelling, we make the best use of available patient scans and stent device mechanics to accurately predict the behaviour of devices inside each patient's vessel configuration. This allows clinicians to optimise device selection, reducing the number of complications and the associated cost of stenting surgeries for hospitals and our society.We are a start-up company specifically created to bring this technology to hospitals. We currently run IUK Biomedical Catalyst Primer (BMC-P) project, and are incubated by The Royal Academy of Engineering. The results of our previous projects have received numerous awards, including the NHS Innovation Award 2017 from Health Enterprise East (HEE). We were named the "Best Healthcare Start-up of 2018" by WIRED magazine and were the national winner at the prestigious Medilink UK Healthcare Business Awards 2017\. We were selected to be part of the Digital Health London Accelerator (DHLA) programme, and previously one of the 6 startups selected globally by Philips Healthcare Accelerator, as well as featured in two Forbes articles as "founders striving to change the world" and "one of the new British start- ups to watch closely", two WIRED articles: "These are the healthcare start-ups you need to know about" and "From AI doctors to 3D X-rays, the future of healthcare is already here", and have been featured in The Times, Financial Times, etc.Our aim is to grow Oxford Heartbeat to be the leading provider of clinical decision support tools, to improve healthcare and define the medicine of tomorrow.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于OUR-HPR综合测量调控生物除磷过程的原理
  • 批准号:
    50908241
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2009
  • 负责人:
    卢培利
  • 依托单位: